Results 201 to 210 of about 11,340 (243)

Clinical features of patients with familial Mediterranean fever over 50 years of age: a single-center experience. [PDF]

open access: yesIntern Emerg Med
Baspinar SN   +14 more
europepmc   +1 more source

Colchicine resistance prediction criteria from the TURPAID cohort do not apply to the JIR cohort: a multicentre descriptive analysis. [PDF]

open access: yesRMD Open
Mertz P   +13 more
europepmc   +1 more source

[Familial Mediterranean fever (FMF)].

open access: yesRevista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion, 1998
openaire   +1 more source

Secondary amyloidosis due to FMF.

open access: yesHepato-gastroenterology, 2007
Familial Mediterranean fever (FMF) is an ethnically restricted disease with an autosomal recessive inheritance characterized by recurrent attacks of fever, painful manifestations in the abdomen, chest and joints. The disease affects mainly non-Ashkenazi Jews, Armenians, Turks Arabs and other people of Mediterranean origin.
Ozlem, Yonem, Yusuf, Bayraktar
openaire   +2 more sources

Febbre Mediterranea familiare (FMF)

open access: yes, 2012
Familial Mediterranean fever (FMF) is also called recurrent polyserositis, and its prominent features include brief recurrent episodes of peritonitis, pleuritis, and arthritis, usually with accompanying fever. FMF occurs within individuals of Mediterranean descent than in persons of any other ethnicity, and genetic testing is now available for ...
Cantarini, L.   +7 more
openaire   +2 more sources

Anti-IL1 treatment in colchicine-resistant paediatric FMF patients: real life data from the HELIOS registry

open access: yesRheumatology, 2020
Objectives. FMF is a prototype of autoinflammatory diseases associated with excess IL1 production. Anti-IL1 treatments are the first-line alternatives in colchicine-resistant/intolerant FMF patients.
Erdal Sag, Fuat Akal, Erdal Atalay
exaly   +2 more sources

Home - About - Disclaimer - Privacy